Disk diffusion was a reliable, easy, and inexpensive method for testing the susceptibility of Campylobacter jejuni to erythromycin (215 susceptible and 45 resistant isolates) and to ciprofloxacin (154 susceptible, two intermediate, and 124 resistant isolates) using, respectively, an erythromycin disk and ciprofloxacin and nalidixic acid disks.Campylobacter jejuni subsp. jejuni (C. jejuni) is a major human pathogen responsible of 85 to 95% of enterocolitis caused by Campylobacter spp. These infections need to be treated with an antimicrobial agent in less than 50% of cases (1). Macrolides and fluoroquinolones are the first-and second-choice antimicrobial agents for that purpose (1,4,8,9,11,13). With the development of resistance of C. jejuni strains to both erythromycin and ciprofloxacin, routine susceptibility testing has become a very important tool for appropriate antimicrobial treatment when needed (4, 6-9, 11, 13). The main erythromycin resistance mechanism of C. jejuni strains (mutation of 23S ribosomal rRNA and proteins) confers a high-level resistance with MICs of Ն128 g/ml (9). The main quinolone resistance mechanism (mutation[s] of DNA gyrase A) can confer a low, intermediate, or high resistance level to ciprofloxacin and confers a high resistance level to nalidixic acid (4,14).Antimicrobial susceptibility testing of Campylobacter spp. with an agar dilution method has been standardized by the CLSI (2), and the erythromycin, ciprofloxacin, tetracycline, and doxycycline MIC interpretive criteria for C. jejuni and Campylobacter coli have been reported previously (3). The agar dilution method, however, is not convenient for testing a few isolates at a time, and the disk diffusion method has not been standardized yet.The aim of this study was to compare the results obtained by the disk diffusion method with those obtained with the reference agar dilution method to test the susceptibility of C. jejuni isolates to erythromycin and ciprofloxacin.